Table 4

Treatments and complications

DEX-implant
(46 eyes)
Bevacizumab
(42 eyes)
P value
Number of eyes that underwent glaucoma surgery (0–5 years)1 (2%)1 (2%)0.95
Number of eyes that had cataract surgery (0–5 years) (% of phakic enrolled eyes)26 (87)23 (72)0.86
Number of eyes that were NPDR at baseline who progressed to PDR (0–5 years)6/311/32<0.05
Average number of treatments for 5-year completers (26 eyes in each group), n (SD)9.0 (6.04)19.2 (7.04)<0.05
  • DEX, dexamethasone; NPDR, non-proliferative diabetic retinopathy.